SVCM
PCVX icon

Saturn V Capital Management’s Vaxcyte PCVX Stock Holding History

Saturn V Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.9M Buy
824,532
+25,592
+3% +$1.39M 8.68% 4
2025
Q4 		$36.9M Buy
798,940
+10,499
+1% +$470K 6.77% 5
2025
Q3 		$28.4M Buy
788,441
+244,220
+45% +$8.09M 6.23% 6
2025
Q2 		$17.7M Buy
544,221
+311,926
+134% +$10.2M 7.17% 4
2025
Q1 		$8.77M Buy
232,295
+28,010
+14% +$2.24M 4.43% 10
2024
Q4 		$16.7M Sell
204,285
-702
-0.3% -$69.7K 6.55% 5
2024
Q3 		$23.4M Sell
204,987
-10,693
-5% -$964K 8.37% 3
2024
Q2 		$16.3M Buy
215,680
+30,505
+16% +$2.08M 6.15% 4
2024
Q1 		$12.6M Buy
+185,175
New +$12.8M 5.07% 9

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return